| Patient | Natsume Sōseki |
|---|---|
| Date of birth | 1983-02-09 |
| Identifiers | MRN HR-ET023-SYN; SSN (made up) 000-23-8840 |
| Document date | 2026-11-01 |
| Author | Haruka Lindqvist-Mori, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
New patient visit for three weeks of epigastric pain with black stools and iron-deficiency anemia, with urgent gastroenterology referral for endoscopy. Concerns: He has had stomach pain for weeks and his stools turned black; he wants to know whether it is cancer; He needs to finish the serial he is writing and fears that illness will stop him. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Acetaminophen 500 mg oral tablet, one or two tablets by mouth every six hours as needed for headache or pain, no more than 3 g a day (in place of ibuprofen) | One or two tablets every six hours as needed; no more than six tablets a day | Oral route | 2026-05-18 | active | S |
| Vonoprazan 20 mg oral tablet, one tablet by mouth each morning for eight weeks for gastric ulcer healing | One tablet each morning for eight weeks | Oral route | 2026-05-21 to 2026-07-16 | completed | S |
| Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet by mouth every other day | One tablet every other morning | Oral route | 2026-05-21 | active | S |
| Vonoprazan 20 mg oral tablet, one extra tablet by mouth each evening for 14 days during eradication therapy (20 mg twice daily with the morning dose) | One tablet each evening for 14 days | Oral route | 2026-06-04 to 2026-06-17 | completed | S |
| Amoxicillin 500 mg oral capsule, two capsules (1 g) by mouth three times daily for 14 days | Two capsules three times daily for 14 days | Oral route | 2026-06-04 to 2026-06-17 | completed | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| Upper endoscopy (esophagogastroduodenoscopy) under light sedation | 2026-05-21 to 2026-05-21 | completed | S |
| Endoscopic biopsies: six from the ulcer margin and five mapping biopsies (updated Sydney protocol), with H. pylori clarithromycin-resistance PCR | 2026-05-21 to 2026-05-21 | completed | S |
| 13C urea breath test, at least four weeks after antibiotics and two weeks after stopping vonoprazan | 2026-08-03 to 2026-08-03 | completed | S |
| Repeat upper endoscopy with biopsy of the ulcer scar | 2026-08-03 to 2026-08-03 | completed | S |
| Advance care planning conversation, about 20 minutes | 2026-06-16 to 2026-06-16 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 2026-06-16 | Tetanus, diphtheria, and acellular pertussis vaccine (Tdap) | completed | S |
| 2026-06-16 | Hepatitis B vaccine (HepB-CpG), dose 1 of 2 | completed | S |
| 2026-08-03 | Hepatitis B vaccine (HepB-CpG), dose 2 of 2 | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| 1900 | A period of severe nervous distress during two years of study in Britain, continuing for some time after his return | D (CLM-0005) |
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
| Concern | Status | Evidence |
|---|---|---|
| He has had stomach pain for weeks and his stools turned black; he wants to know whether it is cancer | active | S |
| He needs to finish the serial he is writing and fears that illness will stop him | active | S |
Most recent measures: Hemoglobin [Mass/volume] in Blood 14 on 2026-08-03; MCV [Entitic mean volume] in Red Blood Cells by Automated count 85 on 2026-08-03; Erythrocyte [DistWidth] in Blood by Automated count 16.9 on 2026-05-18; Leukocytes [#/volume] in Blood by Automated count 6.4 on 2026-05-18; Platelets [#/volume] in Blood by Automated count 418 on 2026-05-18; Ferritin [Mass/volume] in Serum or Plasma 46 on 2026-08-03; Iron [Mass/volume] in Serum or Plasma 38 on 2026-05-18; Iron binding capacity [Mass/volume] in Serum or Plasma 448 on 2026-05-18; Iron saturation [Mass Fraction] in Serum or Plasma 8 on 2026-05-18; Sodium [Moles/volume] in Serum or Plasma 140 on 2026-05-18; Potassium [Moles/volume] in Serum or Plasma 4.2 on 2026-05-18; Urea nitrogen [Mass/volume] in Serum or Plasma 15 on 2026-05-18; Creatinine [Mass/volume] in Serum or Plasma 0.92 on 2026-05-18; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 106 on 2026-05-18; Glucose [Mass/volume] in Serum or Plasma 96 on 2026-05-18; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 3 on 2026-08-03; Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 4 on 2026-08-03; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 on 2026-06-16; Total score [AUDIT-C] 1 on 2026-06-16; Hemoglobin A1c/Hemoglobin.total in Blood 5.8 on 2026-06-16; Cholesterol [Mass/volume] in Serum or Plasma 186 on 2026-06-16; Cholesterol in HDL [Mass/volume] in Serum or Plasma 56 on 2026-06-16; Triglyceride [Mass/volume] in Serum or Plasma 96 on 2026-06-16; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 111 on 2026-06-16 [S]
Strengths and supports: Supports: his family, his students and friends, and his work [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| About three weeks of gnawing epigastric pain, worse before meals and at night and eased by food, with two episodes of black, tarry stools ten days ago and iron-deficiency anemia; stable, Glasgow-Blatchford score 4; peptic ulcer suspected and urgent endoscopy booked | resolved | confirmed | R10.13 | S — Synthetic presenting concern at the index visit, superseded by the diagnosis at endoscopy; its timing echoes his documented stomach illness of May 1910 (D). |
| Gastric ulcer, 15 mm, on the lesser curvature at the angulus, with recent bleeding (melena) and a clean base at endoscopy (Forrest III); margin biopsies benign; Helicobacter pylori positive; synthetic modern diagnosis for his documented gastric ulcer | resolved | confirmed | K25.4 | S — Synthetic modern diagnosis anchored to his documented gastric ulcer (D); the Helicobacter pylori cause is synthetic. |
| Helicobacter pylori infection (rapid urease test and histology positive; clarithromycin resistance mutation on biopsy PCR) | resolved | confirmed | B96.81 | S — Synthetic finding at endoscopy; no historical claim is made about the organism in his illness. |
| Iron-deficiency anemia from chronic blood loss (hemoglobin 11.2 g/dL, MCV 76 fL, ferritin 8 ng/mL) | active | confirmed | D50.0 | S — Synthetic finding at intake. |
| Acute low back strain after lifting a box of books, without red flags, managed without NSAIDs because of the gastric ulcer; resolved | resolved | confirmed | M54.50 | S — Synthetic intercurrent illness; not a historical claim. |
| Prediabetes (hemoglobin A1c 5.8%) | active | confirmed | R73.03 | S — Synthetic finding at the preventive visit; not a claim about his real health at this age. |
| Chronic atrophic gastritis from Helicobacter pylori, moderate atrophy with focal intestinal metaplasia in the antrum (OLGA stage II, OLIM stage I; open-type endoscopic atrophy); no dysplasia; yearly endoscopic surveillance | active | confirmed | K29.40 | S — Synthetic histology finding at the two-week visit; not a historical claim. |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-05-18 | Hemoglobin [Mass/volume] in Blood | 11.2 | g/dL | 13.2-17.1 g/dL | Low | S |
| 2026-05-18 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 76 | fL | 80-100 fL | Low | S |
| 2026-05-18 | Erythrocyte [DistWidth] in Blood by Automated count | 16.9 | % | 11.5-15% | High | S |
| 2026-05-18 | Leukocytes [#/volume] in Blood by Automated count | 6.4 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 2026-05-18 | Platelets [#/volume] in Blood by Automated count | 418 | 10*3/uL | 150-400 10*3/uL | High | S |
| 2026-05-18 | Ferritin [Mass/volume] in Serum or Plasma | 8 | ng/mL | 30 ng/mL or less indicates iron deficiency (AGA) | Low | S |
| 2026-05-18 | Iron [Mass/volume] in Serum or Plasma | 38 | ug/dL | 65-175 ug/dL | Low | S |
| 2026-05-18 | Iron binding capacity [Mass/volume] in Serum or Plasma | 448 | ug/dL | 250-425 ug/dL | High | S |
| 2026-05-18 | Iron saturation [Mass Fraction] in Serum or Plasma | 8 | % | 20-50% | Low | S |
| 2026-05-18 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-05-18 | Potassium [Moles/volume] in Serum or Plasma | 4.2 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-05-18 | Urea nitrogen [Mass/volume] in Serum or Plasma | 15 | mg/dL | 7-20 mg/dL | Normal | S |
| 2026-05-18 | Creatinine [Mass/volume] in Serum or Plasma | 0.92 | mg/dL | 0.7-1.3 mg/dL | Normal | S |
| 2026-05-18 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 106 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-05-18 | Glucose [Mass/volume] in Serum or Plasma | 96 | mg/dL | 70-139 mg/dL | Normal | S |
| 2026-05-18 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 7 | {score} | S | ||
| 2026-05-18 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 8 | {score} | S | ||
| 2026-05-21 | Hemoglobin [Mass/volume] in Blood | 11 | g/dL | 13.2-17.1 g/dL | Low | S |
| 2026-06-04 | Hemoglobin [Mass/volume] in Blood | 11.8 | g/dL | 13.2-17.1 g/dL | Low | S |
| 2026-08-03 | Hemoglobin [Mass/volume] in Blood | 14 | g/dL | 13.2-17.1 g/dL | Normal | S |
| 2026-08-03 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 85 | fL | 80-100 fL | Normal | S |
| 2026-08-03 | Ferritin [Mass/volume] in Serum or Plasma | 46 | ng/mL | 30 ng/mL or less indicates iron deficiency (AGA) | Normal | S |
| 2026-08-03 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 3 | {score} | S | ||
| 2026-08-03 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 4 | {score} | S | ||
| 2026-06-16 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | {score} | S | ||
| 2026-06-16 | Total score [AUDIT-C] | 1 | {score} | S | ||
| 2026-06-16 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.8 | % | Below 5.7% is normal; 5.7 to 6.4% prediabetes | High | S |
| 2026-06-16 | Cholesterol [Mass/volume] in Serum or Plasma | 186 | mg/dL | <=199 mg/dL | Normal | S |
| 2026-06-16 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 56 | mg/dL | >=40 mg/dL | Normal | S |
| 2026-06-16 | Triglyceride [Mass/volume] in Serum or Plasma | 96 | mg/dL | <=149 mg/dL | Normal | S |
| 2026-06-16 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 111 | mg/dL | <=129 mg/dL | Normal | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-05-18 | Body height | 159 | cm | S |
| 2026-05-18 | Body weight | 52 | kg | S |
| 2026-05-18 | Body mass index (BMI) [Ratio] | 20.6 | kg/m2 | S |
| 2026-05-18 | Systolic blood pressure | 124 | mm[Hg] | S |
| 2026-05-18 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 2026-05-18 | Heart rate | 84 | /min | S |
| 2026-05-18 | Respiratory rate | 14 | /min | S |
| 2026-05-18 | Body temperature | 36.6 | Cel | S |
| 2026-05-18 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 2026-05-21 | Body height | 159 | cm | S |
| 2026-05-21 | Body weight | 51.8 | kg | S |
| 2026-05-21 | Body mass index (BMI) [Ratio] | 20.5 | kg/m2 | S |
| 2026-05-21 | Systolic blood pressure | 122 | mm[Hg] | S |
| 2026-05-21 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-05-21 | Heart rate | 82 | /min | S |
| 2026-05-21 | Respiratory rate | 14 | /min | S |
| 2026-05-21 | Body temperature | 36.5 | Cel | S |
| 2026-05-21 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 2026-06-04 | Body height | 159 | cm | S |
| 2026-06-04 | Body weight | 52.2 | kg | S |
| 2026-06-04 | Body mass index (BMI) [Ratio] | 20.6 | kg/m2 | S |
| 2026-06-04 | Systolic blood pressure | 120 | mm[Hg] | S |
| 2026-06-04 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-06-04 | Heart rate | 78 | /min | S |
| 2026-06-04 | Respiratory rate | 14 | /min | S |
| 2026-06-04 | Body temperature | 36.6 | Cel | S |
| 2026-06-04 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 2026-08-03 | Body height | 159 | cm | S |
| 2026-08-03 | Body weight | 53.6 | kg | S |
| 2026-08-03 | Body mass index (BMI) [Ratio] | 21.2 | kg/m2 | S |
| 2026-08-03 | Systolic blood pressure | 118 | mm[Hg] | S |
| 2026-08-03 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 2026-08-03 | Heart rate | 72 | /min | S |
| 2026-08-03 | Respiratory rate | 14 | /min | S |
| 2026-08-03 | Body temperature | 36.6 | Cel | S |
| 2026-08-03 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 2026-06-11 | Body height | 159 | cm | S |
| 2026-06-11 | Body weight | 52.4 | kg | S |
| 2026-06-11 | Body mass index (BMI) [Ratio] | 20.7 | kg/m2 | S |
| 2026-06-11 | Systolic blood pressure | 126 | mm[Hg] | S |
| 2026-06-11 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 2026-06-11 | Heart rate | 80 | /min | S |
| 2026-06-11 | Respiratory rate | 14 | /min | S |
| 2026-06-11 | Body temperature | 36.6 | Cel | S |
| 2026-06-11 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 2026-06-16 | Body height | 159 | cm | S |
| 2026-06-16 | Body weight | 52.6 | kg | S |
| 2026-06-16 | Body mass index (BMI) [Ratio] | 20.8 | kg/m2 | S |
| 2026-06-16 | Systolic blood pressure | 120 | mm[Hg] | S |
| 2026-06-16 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-06-16 | Heart rate | 74 | /min | S |
| 2026-06-16 | Respiratory rate | 14 | /min | S |
| 2026-06-16 | Body temperature | 36.5 | Cel | S |
| 2026-06-16 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 2026-05-18 | New patient visit for three weeks of epigastric pain with black stools and iron-deficiency anemia, with urgent gastroenterology referral for endoscopy | finished | S |
| 2026-05-21 | Gastroenterology consultation with upper endoscopy and biopsy, diagnosis of gastric ulcer, and start of vonoprazan and iron | finished | S |
| 2026-06-04 | Two-week review: biopsy results, Helicobacter pylori resistance testing, and start of eradication therapy | finished | S |
| 2026-08-03 | Eleven-week review: urea breath test, repeat endoscopy for ulcer healing, anemia, and surveillance planning | finished | S |
| 2026-06-11 | Same-day sick visit for acute low back strain, managed without NSAIDs | finished | S |
| 2026-06-16 | Periodic adult preventive visit | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Initial evaluation and safety: blood count, iron studies and metabolic panel; Glasgow-Blatchford score; stop ibuprofen and all NSAIDs and use acetaminophen; urgent upper endoscopy within three days; no acid-suppressing medicine or antibiotic before the biopsies unless bleeding recurs; call 119 or go to the emergency department at once for black or bloody stools, vomiting blood or coffee-ground material, fainting, or severe pain | completed | GL-ACG-UGIB-2021, GL-JSGE-PUD-2026, GL-ACG-HP-2024 | S |
| Urgent gastroenterology consultation for upper endoscopy with biopsy within three days, to find the cause of the bleeding, exclude gastric cancer, test for Helicobacter pylori, and advise on treatment | completed | GL-JSGE-PUD-2026, GL-ACG-UGIB-2021 | S |
| Iron-deficiency anemia: oral iron once the source is found at endoscopy; blood count about four weeks after starting iron and then every three months for a year; continue iron about three months after the hemoglobin is normal and until ferritin is replete; colonoscopy if the anemia does not correct once the ulcer has healed | completed | GL-CMID-2026 | S |
| Stress and sleep: PHQ-9 and GAD-7 at intake and at the end of the episode; regular meals, a fixed bedtime, and writing hours that leave the evening free; counselling if scores rise | completed | GL-USPSTF-DEP-2023 | S |
| Gastric ulcer and Helicobacter pylori: vonoprazan 20 mg each morning for eight weeks; eradication chosen by the biopsy resistance result (vonoprazan 20 mg twice daily with amoxicillin 1 g three times daily for 14 days for a clarithromycin-resistant strain); 13C urea breath test at least four weeks after the antibiotics and two weeks after vonoprazan; repeat endoscopy with biopsy of the scar at about ten weeks | completed | GL-ACG-HP-2024, GL-MAASTRICHT-VI-2022, GL-JSHR-HP-2016, GL-JSGE-PUD-2026 | S |
| Gastric cancer surveillance after eradication: upper endoscopy yearly because of moderate atrophy with intestinal metaplasia in the antrum (OLGA stage II), lifelong; no smoking, little alcohol and less salt | completed | GL-MAASTRICHT-VI-2022, GL-JSHR-HP-2016, GL-ACG-HP-2024 | S |
| Acute low back strain: stay active, superficial heat, gentle stretching, and acetaminophen up to 3 g a day for a few days; no ibuprofen, naproxen, aspirin or other NSAID, including topical or combination cold remedies, while the ulcer heals and preferably for good; finish the eradication course; return for leg weakness, numbness in the saddle area, loss of bladder or bowel control, fever, or pain that is not easing in four weeks | completed | GL-ACP-LBP-2017, GL-JSGE-PUD-2026 | S |
| Prediabetes: walking at least 150 minutes a week, regular meals with less refined rice and sweets, and weight kept steady; repeat A1c in three months once iron is replete, then yearly | completed | GL-USPSTF-DM-2021 | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| Endoscopy within three days of the first visit, with cancer excluded by biopsy | 2026-06-04 | completed | Endoscopy three days after the first visit; margin biopsies benign at two weeks | S |
| No further bleeding and no emergency admission through the episode | 2026-08-03 | completed | No further black stools or vomiting of blood; no admission | S |
| Helicobacter pylori eradicated, confirmed by urea breath test | 2026-08-03 | completed | Urea breath test negative seven weeks after therapy | S |
| Gastric ulcer healed at repeat endoscopy | 2026-08-03 | completed | Healed to a white scar at repeat endoscopy; scar biopsies sent | S |
| Hemoglobin normal and ferritin above 50 ng/mL | 2026-08-03 | active | Hemoglobin 14.0 g/dL; ferritin 46 ng/mL, iron continuing | S |